Viewing Study NCT05438368


Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2026-01-29 @ 3:49 AM
Study NCT ID: NCT05438368
Status: RECRUITING
Last Update Posted: 2022-06-30
First Post: 2022-06-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: GD2/CD70 Bi-specific CAR-T Cell Therapy
Sponsor: Shenzhen Geno-Immune Medical Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAR-T View
None cancer View
None GD2 View
None CD70 View